Fermentation usually grows by buying a bigger tank. Pow.Bio split the job between two tanks, taught software to mind the process, and found that the smarter factory may be the smaller one.
The Shanghai startup is building a bench-to-tank ingredient business - pairing engineered biology with its own production capacity. Its lesson for biotech founders is simple: design for the factory before the experiment becomes precious.
Novozymes and Chr. Hansen spent a century turning bacteria and enzymes into industrial ingredients. In 2024 they became one company - and quietly one of the biggest biotech businesses you have never heard of.
CJ CheilJedang turned Korean pantry staples into a global frozen-food business. Behind the dumplings is a second company built on fermentation, amino acids and a bet that microbes can make better materials.
Solarbiotech is a U.S.-based synthetic biology and biomanufacturing company that helps companies move precision-fermentation products from lab bench to commercial scale. Built around a Norton, Virginia plant with fermentation capacity from 6L to 10,000L and a modular 'BioNodes' architecture, it offers end-to-end strain-to-shelf services - upstream fermentation, downstream processing, and commercial production - for food ingredients, nutraceuticals, cosmetics, enzymes, and industrial bioproducts. After a 2024 Chapter 11 restructuring, its assets were acquired by Pictor Biotech (led by ex-Novozymes executive Peter Rosholm) and unified in January 2025 with GPC Bio and Eleszto Genetika into a vertically integrated, 100+ person SynBio platform.